cyc 202 has been researched along with Carcinoma, Pancreatic Ductal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kizhake, S; Natarajan, A; Rana, S; Sonawane, YA; Taylor, MA; Zahid, M | 1 |
| Cloyd, JM; Du, S; Mao, Y; Pawlik, TM; Xiao, Y; Xu, G; Zhang, B | 1 |
| Chu, Q; Wang, L; Wang, W; Wang, Y; Zhang, J | 1 |
| Andersen, JM; Caffrey, TC; Collisson, EC; Eggers, JP; Grandgenett, PM; High, RR; Hollingsworth, MA; Lewallen, ME; Ouellette, M; Singh, PK; Swanson, BJ; Tremayne, J | 1 |
4 other study(ies) available for cyc 202 and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Synthesis of aminopyrazole analogs and their evaluation as CDK inhibitors for cancer therapy.
Topics: Amination; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 5; Humans; Molecular Docking Simulation; Pancreatic Neoplasms; Protein Kinase Inhibitors; Pyrazoles; Structure-Activity Relationship | 2018 |
Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
Topics: Aurora Kinase A; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Computational Biology; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genome-Wide Association Study; Humans; Lapatinib; Pancreatic Neoplasms; Prospective Studies; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); RNA; Roscovitine; Serine; Threonine; Trypsin | 2022 |
CDK5 positively regulates Notch1 signaling in pancreatic cancer cells by phosphorylation.
Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinase 5; Dipeptides; Gene Silencing; Humans; Immunoprecipitation; Pancreatic Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Receptor, Notch1; RNA, Messenger; Roscovitine; Signal Transduction | 2021 |
Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase 5; Disease Progression; Enzyme Activation; Gene Amplification; Genes, ras; Humans; Mutation; Neoplasm Invasiveness; Nerve Tissue Proteins; Pancreatic Neoplasms; Purines; Roscovitine | 2011 |